US89377M1099
US89377M1099
TransMedics Group, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 605.494.000 | 441.540.000 | 37.1% |
| Cost of Revenue | 242.688.000 | 179.459.000 | 35.2% |
| Gross Profit | 362.806.000 | 262.081.000 | 38.4% |
| 254.223.000 | 224.585.000 | 13.2% | |
| Operating Income | 108.583.000 | 37.496.000 | 189.6% |
| Pretax Income | 107.522.000 | 35.780.000 | 200.5% |
| Net Income Common Stockholders | 190.291.000 | 35.464.000 | 436.6% |
| -- | -- | -- | |
| -- | -- | -- |